Determining how C-terminal methylation regulates PP2A, PP4, and PP6 holoenzyme composition is important because changes in holoenzyme assembly are linked to human diseases, including Alzheimer’s Disease (AD) and cancer. This evidence concerns the gene PPP6C and early-onset autosomal dominant Alzheimer disease.